Malignant pleural mesothelioma (MPM) is the most common primary pleural tumor and its incidence is rising. Its diagnosis, staging and response assessment are challenging for imaging. Integrated positron emission tomography (PET)/CT increases the accuracy of overall staging in patients with mesothelioma and improves the selection of patients for curative surgical resection. It is particularly useful in identifying occult distant metastases. It may be used to predict prognosis and to assess the metabolic response to therapy.
|Original language||English (US)|
|Number of pages||10|
|Journal||Journal of Medical Imaging and Radiation Oncology|
|State||Published - Apr 2009|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging